Mirum Pharmaceuticals, Inc.
MIRM
$100.64
$1.871.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1,368.86% | -932.90% | 73.43% | 58.50% | 46.35% |
| Total Depreciation and Amortization | 7.13% | 4.37% | 2.60% | 5.02% | 23.10% |
| Total Amortization of Deferred Charges | 17.12% | 4.76% | 4.70% | 4.56% | 4.23% |
| Total Other Non-Cash Items | 773.10% | 783.03% | 44.73% | 18.42% | 19.98% |
| Change in Net Operating Assets | 389.58% | 841.63% | -187.27% | -143.92% | -267.27% |
| Cash from Operations | -2,626.59% | -2,396.71% | 440.70% | 3,748.33% | 138.39% |
| Capital Expenditure | -300.54% | -54.46% | 3.93% | 61.56% | 53.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -330.85% | 83.07% | 74.20% | 73.91% | 9.51% |
| Cash from Investing | -330.57% | 81.75% | 73.42% | 73.78% | 84.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,172.34% | 1,267.27% | 126.80% | 153.06% | -88.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,989.12% | 1,229.64% | 126.80% | 158.09% | -88.85% |
| Foreign Exchange rate Adjustments | -235.88% | 352.11% | 348.42% | 1,084.74% | 1,034.27% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,222.62% | 226.27% | 218.67% | 174.19% | 92.32% |